Available Until 5/14/2027

Clinical Updates in Specialty Neurology Pharmacotherapy

Planned in cooperation with the Section of Specialty Pharmacy Practitioners Educational Steering Committee  

ACPE Activity Number: 0204-0000-24-071-H01-P
Release Date:  May 14, 2024
Expiration Date: May 14, 2027
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEUs)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

As the specialty pharmacy pipeline continues to rapidly evolve, there are many unique usage criteria for newly approved medications. This webinar will cover updates in disease state findings and treatment strategies in specialty neurology therapeutic areas.  

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity was planned to meet the educational needs of pharmacists providing care for patients with neurologic conditions and specialty pharmacists who manage specialty medications used for neurologic conditions.  

After completing this activity, the learner should be able to…

  • Identify updates in disease state findings and treatment strategies in specialty neurology therapeutic areas.
  • Summarize the role of newly approved and pipeline specialty therapies including mechanism of action, dosing, efficacy, and safety in the treatment of specialty neurology conditions.
  • Discuss usage criteria of specialty neurological medications, including storage, handling, administration, and other special considerations. 

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Alexis El-Khouri, PharmD
Clinical Specialty Pharmacist, CPS Solutions
Akron OH  

Aimee M. Banks, PharmD, BCPS, MSCS
Clinical Pharmacist, Multiple Sclerosis
Vanderbilt University Medical Center 
Nashville, TN 37215 

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.